Euclidean Capital LLC

Euclidean Capital LLC reported 10 holdings worth US$324M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Euclidean Capital LLC reported 10 holdings worth US$324M as of Sep 30, 2026. Largest: Vanguard FTSE All-World ex-US Index Fund, iShares MSCI India ETF and ORIC Pharmaceuticals, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
10
Value as reported
US$324M

The filing in full

CompanySharesValue as reported% of portfolio
Vanguard FTSE All-World ex-US Index Fund3.24MUS$269M83.2%
iShares MSCI India ETF370KUS$17.3M5.3%
ORIC Pharmaceuticals, Inc.989KUS$13.3M4.1%
Teamshares Inc.1.1MUS$7.99M2.5%
Foghorn Therapeutics Inc.1.57MUS$5.62M1.7%
PMV Pharmaceuticals, Inc.2.63MUS$4.39M1.4%
Surrozen, Inc.87,696US$2.82M0.87%
Alector, Inc.1.31MUS$2.42M0.75%
Tenaya Therapeutics, Inc.1.02MUS$613K0.19%
Merlin, Inc.47,610US$89,5070.03%

Source

Download original · View original at SEC

Related